Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.58 |
| ▸ | ALB | P02768 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.38 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.37 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2785702 | 0.84 | MMP3 (0.55) | TTRALBCA12CA2CA3 | |
| SCHEMBL3567872 | 0.82 | TTR (0.52) | TTRALBCA12CA2CA3 | |
| SCHEMBL30250891 | 0.82 | TTR (0.52) | TTRALBCA12CA2CA3 | |
| SCHEMBL321522 | 0.79 | XDH (0.56) | TTRALBENPP2 | |
| SCHEMBL7125883 | 0.79 | MMP3 (0.66) | TTRALBCA12CA2CA3 | |
| SCHEMBL21687453 | 0.78 | TTR (0.52) | TTRALBCA12CA2CA3 | |
| SCHEMBL29449995 | 0.78 | CA12 (0.52) | TTRALBCA12CA2CA3 | |
| SCHEMBL217250 | 0.78 | CA12 (0.52) | TTRALBCA12CA2CA3 | |
| SCHEMBL2785232 | 0.78 | TTR (0.41) | TTRALBCYP19A1MMP3KDM1A | |
| SCHEMBL23271632 | 0.76 | CA12 (0.50) | TTRALBCA12CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101497589-B | Method for synthesizing 2-(3-cyano-4- isobutoxy phenyl)-4-methyl-carboxylate | UNIV SHENYANG PHARMACEUTICAL | 2012-08-29 | — | — | CN | claimed |
| CN-101497589-A | Method for synthesizing 2-(3-cyano-4- isobutoxy phenyl)-4-methyl-carboxylate | UNIV SHENYANG PHARMACEUTICAL (CN) | 2009-08-05 | — | — | CN | claimed |
| JP-4226903-A | — | — | None | — | — | JP | disclosed |
| JP-1168603-A | — | — | None | — | — | JP | disclosed |
| CN-118561693-A | Preparation method of nitroaromatic compound and compound | 大连理工大学 | 2024-08-30 | — | — | CN | disclosed |
| US-20240287104-A1 | NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY | RIGSHOSPITALET [DK]/[DK] (DK) | 2024-08-29 | — | — | US | disclosed |
| US-20240027902-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| WO-2023240138-A1 | INDAZOLE CONTAINING MACROCYCLES AND THEIR USE | BLOSSOMHILL THERAPEUTICS, INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| US-20230305394-A1 | RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-28 | — | — | US | disclosed |
| US-20230305393-A1 | RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-28 | — | — | US | disclosed |
| US-11720018-B2 | Chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| WO-2002074758-A2 | NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS | ABBOTT LABORATORIES (US) | 2002-09-26 | — | — | WO | disclosed |
| EP-1222182-A2 | SUBSTITUTED (AMINOIMINOMETHYL OR AMINOMETHYL) DIHYDROBENZOFURANS AND BENOZOPYRANS | Aventis Pharmaceuticals Inc. (US) | 2002-07-17 | — | — | EP | disclosed |
| WO-2002016340-A1 | AMINOALKOXYBENZOYL-BENZOFURAN OR BENZOTHIOPHENE DERIVATIVES, METHOD FOR PREPARING SAME AND COMPOSITIONS CONTAINING SAME | SANOFI-SYNTHELABO (FR) | 2002-02-28 | — | — | WO | disclosed |
| WO-2001014358-A2 | SUBSTITUTED (AMINOIMINOMETHYL OR AMINOMETHYL) DIHYDROBENZOFURANS AND BENOZOPYRANS | AVENTIS PHARMACEUTICALS INC. (DE) | 2001-03-01 | — | — | WO | disclosed |
| JP-H04226903-A | COMPOUND HERBICIDE COMPRISING AT LEAST ONE KIND SELECTED FROM BROMOXYNIL, IOXYNIL AND DERIVATIVE THEREOF AND 2-CHLORO-6-NITRO-3-PHENOXYANILINE | RHONE POULENC AGROCHIM | 1992-08-17 | — | — | JP | disclosed |
| US-5129937-A | Pre- and postemergence; soybean, cotton, corn; injury free | MITSUI TOATSU CHEMICALS INCORPORATED (JP) | 1992-07-14 | — | — | US | disclosed |
| EP-0435186-A2 | Pyridyloxypyrimidine derivatives, preparation process thereof, and herbicidal compositions containing the same as active ingredients | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1991-07-03 | — | — | EP | disclosed |
| JP-H01168603-A | SYNERGIC COMPOSITION FOR SELECTIVELY CONTROLLING WEED IN GROWING AREA OF USEFUL PLANT | CIBA GEIGY AG | 1989-07-04 | — | — | JP | disclosed |
| EP-0219143-A1 | Synergistic herbicidal compositions and methods of use | STAUFFER CHEMICAL COMPANY (US) | 1987-04-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287104-A1 | NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY | HUNK, NUCB2, TK1 | TTR 501/4885ALB 3179/4885CA12 749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.